Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==
Deborah H. Yellin
Partner
She/Her/Hers
- Washington, D.C.
  - D | +1.202.624.2947
ZHllbGxpbkBjcm93ZWxsLmNvbQ==

Insights

Publication | 03.31.25

Health System Settles FCA Case Over PPP Loan 03.31.25 Report on Medicare Compliance

Publication | 03.26.25
Conducting Investigations And Discovery In China: What Companies Need To Consider In Preparing For New Policies
Publication | 03.24.25
UK Adds Debarment List To Procurement Regime For 2025
Publication | 03.17.25
Navigating Uncertainty: Implications Of Trump Administration’s Approach To Infrastructure

View All Insights

Subscribe

to the latest insights from our team